The global market for Antimycobacterial Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Antimycobacterial drugs are used to treat infections caused by members of Mycobacterium genus. Mycobacterium genus includes M. tuberculosis, M. leprae, and M. avium-intracellulare which cause tuberculosis, leprosy, and atypical mycobacteria, respectively.

The hospital pharmacies segment dominated the antimycobacterial drugs market in 2017 due to easy availability of leprosy and tuberculosis medications in government hospitals. The segment is expected to continue to dominate the market from 2018 to 2025.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Antimycobacterial Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antimycobacterial Drugs.

The Antimycobacterial Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antimycobacterial Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Antimycobacterial Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Antimycobacterial Drugs Market Report

Report Metric	Details
Report Name	Antimycobacterial Drugs Market
Segment by Type	Drugs Used for Tuberculosis Drugs Used for Leprosy Drugs Used for Atypical Mycobacteria
Segment by Application	Hospital Pharmacies Retail Pharmacies Online Pharmacies
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Pfizer, Novartis, GlaxoSmithKline, Bayer, AstraZeneca, Sanofi, Merck, Lupin, Macleods Pharmaceuticals, Systopic Laboratories, Zydus Cadila
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antimycobacterial Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Antimycobacterial Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Antimycobacterial Drugs Market report?

Ans: The main players in the Antimycobacterial Drugs Market are Pfizer, Novartis, GlaxoSmithKline, Bayer, AstraZeneca, Sanofi, Merck, Lupin, Macleods Pharmaceuticals, Systopic Laboratories, Zydus Cadila

What are the Application segmentation covered in the Antimycobacterial Drugs Market report?

Ans: The Applications covered in the Antimycobacterial Drugs Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Antimycobacterial Drugs Market report?

Ans: The Types covered in the Antimycobacterial Drugs Market report are Drugs Used for Tuberculosis, Drugs Used for Leprosy, Drugs Used for Atypical Mycobacteria

1 Antimycobacterial Drugs Market Overview

1.1 Product Definition

1.2 Antimycobacterial Drugs by Type

1.2.1 Global Antimycobacterial Drugs Market Value Comparison by Type (2024 VS 2031)

1.2.2 Drugs Used for Tuberculosis

1.2.3 Drugs Used for Leprosy

1.2.4 Drugs Used for Atypical Mycobacteria

1.3 Antimycobacterial Drugs by Application

1.3.1 Global Antimycobacterial Drugs Market Value by Application (2024 VS 2031)

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Global Antimycobacterial Drugs Market Size Estimates and Forecasts

1.4.1 Global Antimycobacterial Drugs Revenue 2020-2031

1.4.2 Global Antimycobacterial Drugs Sales 2020-2031

1.4.3 Global Antimycobacterial Drugs Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Antimycobacterial Drugs Market Competition by Manufacturers

2.1 Global Antimycobacterial Drugs Sales Market Share by Manufacturers (2020-2025)

2.2 Global Antimycobacterial Drugs Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Antimycobacterial Drugs Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Antimycobacterial Drugs, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Antimycobacterial Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Antimycobacterial Drugs, Product Type & Application

2.7 Global Key Manufacturers of Antimycobacterial Drugs, Date of Enter into This Industry

2.8 Global Antimycobacterial Drugs Market Competitive Situation and Trends

2.8.1 Global Antimycobacterial Drugs Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Antimycobacterial Drugs Players Market Share by Revenue

2.8.3 Global Antimycobacterial Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Antimycobacterial Drugs Market Scenario by Region

3.1 Global Antimycobacterial Drugs Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Antimycobacterial Drugs Sales by Region: 2020-2031

3.2.1 Global Antimycobacterial Drugs Sales by Region: 2020-2025

3.2.2 Global Antimycobacterial Drugs Sales by Region: 2026-2031

3.3 Global Antimycobacterial Drugs Revenue by Region: 2020-2031

3.3.1 Global Antimycobacterial Drugs Revenue by Region: 2020-2025

3.3.2 Global Antimycobacterial Drugs Revenue by Region: 2026-2031

3.4 North America Antimycobacterial Drugs Market Facts & Figures by Country

3.4.1 North America Antimycobacterial Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Antimycobacterial Drugs Sales by Country (2020-2031)

3.4.3 North America Antimycobacterial Drugs Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Antimycobacterial Drugs Market Facts & Figures by Country

3.5.1 Europe Antimycobacterial Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Antimycobacterial Drugs Sales by Country (2020-2031)

3.5.3 Europe Antimycobacterial Drugs Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Antimycobacterial Drugs Market Facts & Figures by Region

3.6.1 Asia Pacific Antimycobacterial Drugs Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Antimycobacterial Drugs Sales by Region (2020-2031)

3.6.3 Asia Pacific Antimycobacterial Drugs Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Antimycobacterial Drugs Market Facts & Figures by Country

3.7.1 Latin America Antimycobacterial Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Antimycobacterial Drugs Sales by Country (2020-2031)

3.7.3 Latin America Antimycobacterial Drugs Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Antimycobacterial Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Antimycobacterial Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Antimycobacterial Drugs Sales by Country (2020-2031)

3.8.3 Middle East and Africa Antimycobacterial Drugs Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Antimycobacterial Drugs Sales by Type (2020-2031)

4.1.1 Global Antimycobacterial Drugs Sales by Type (2020-2025)

4.1.2 Global Antimycobacterial Drugs Sales by Type (2026-2031)

4.1.3 Global Antimycobacterial Drugs Sales Market Share by Type (2020-2031)

4.2 Global Antimycobacterial Drugs Revenue by Type (2020-2031)

4.2.1 Global Antimycobacterial Drugs Revenue by Type (2020-2025)

4.2.2 Global Antimycobacterial Drugs Revenue by Type (2026-2031)

4.2.3 Global Antimycobacterial Drugs Revenue Market Share by Type (2020-2031)

4.3 Global Antimycobacterial Drugs Price by Type (2020-2031)

5 Segment by Application

5.1 Global Antimycobacterial Drugs Sales by Application (2020-2031)

5.1.1 Global Antimycobacterial Drugs Sales by Application (2020-2025)

5.1.2 Global Antimycobacterial Drugs Sales by Application (2026-2031)

5.1.3 Global Antimycobacterial Drugs Sales Market Share by Application (2020-2031)

5.2 Global Antimycobacterial Drugs Revenue by Application (2020-2031)

5.2.1 Global Antimycobacterial Drugs Revenue by Application (2020-2025)

5.2.2 Global Antimycobacterial Drugs Revenue by Application (2026-2031)

5.2.3 Global Antimycobacterial Drugs Revenue Market Share by Application (2020-2031)

5.3 Global Antimycobacterial Drugs Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Pfizer

6.1.1 Pfizer Company Information

6.1.2 Pfizer Description and Business Overview

6.1.3 Pfizer Antimycobacterial Drugs Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Pfizer Antimycobacterial Drugs Product Portfolio

6.1.5 Pfizer Recent Developments/Updates

6.2 Novartis

6.2.1 Novartis Company Information

6.2.2 Novartis Description and Business Overview

6.2.3 Novartis Antimycobacterial Drugs Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Novartis Antimycobacterial Drugs Product Portfolio

6.2.5 Novartis Recent Developments/Updates

6.3 GlaxoSmithKline

6.3.1 GlaxoSmithKline Company Information

6.3.2 GlaxoSmithKline Description and Business Overview

6.3.3 GlaxoSmithKline Antimycobacterial Drugs Sales, Revenue and Gross Margin (2020-2025)

6.3.4 GlaxoSmithKline Antimycobacterial Drugs Product Portfolio

6.3.5 GlaxoSmithKline Recent Developments/Updates

6.4 Bayer

6.4.1 Bayer Company Information

6.4.2 Bayer Description and Business Overview

6.4.3 Bayer Antimycobacterial Drugs Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Bayer Antimycobacterial Drugs Product Portfolio

6.4.5 Bayer Recent Developments/Updates

6.5 AstraZeneca

6.5.1 AstraZeneca Company Information

6.5.2 AstraZeneca Description and Business Overview

6.5.3 AstraZeneca Antimycobacterial Drugs Sales, Revenue and Gross Margin (2020-2025)

6.5.4 AstraZeneca Antimycobacterial Drugs Product Portfolio

6.5.5 AstraZeneca Recent Developments/Updates

6.6 Sanofi

6.6.1 Sanofi Company Information

6.6.2 Sanofi Description and Business Overview

6.6.3 Sanofi Antimycobacterial Drugs Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Sanofi Antimycobacterial Drugs Product Portfolio

6.6.5 Sanofi Recent Developments/Updates

6.7 Merck

6.7.1 Merck Company Information

6.7.2 Merck Description and Business Overview

6.7.3 Merck Antimycobacterial Drugs Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Merck Antimycobacterial Drugs Product Portfolio

6.7.5 Merck Recent Developments/Updates

6.8 Lupin

6.8.1 Lupin Company Information

6.8.2 Lupin Description and Business Overview

6.8.3 Lupin Antimycobacterial Drugs Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Lupin Antimycobacterial Drugs Product Portfolio

6.8.5 Lupin Recent Developments/Updates

6.9 Macleods Pharmaceuticals

6.9.1 Macleods Pharmaceuticals Company Information

6.9.2 Macleods Pharmaceuticals Description and Business Overview

6.9.3 Macleods Pharmaceuticals Antimycobacterial Drugs Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Macleods Pharmaceuticals Antimycobacterial Drugs Product Portfolio

6.9.5 Macleods Pharmaceuticals Recent Developments/Updates

6.10 Systopic Laboratories

6.10.1 Systopic Laboratories Company Information

6.10.2 Systopic Laboratories Description and Business Overview

6.10.3 Systopic Laboratories Antimycobacterial Drugs Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Systopic Laboratories Antimycobacterial Drugs Product Portfolio

6.10.5 Systopic Laboratories Recent Developments/Updates

6.11 Zydus Cadila

6.11.1 Zydus Cadila Company Information

6.11.2 Zydus Cadila Description and Business Overview

6.11.3 Zydus Cadila Antimycobacterial Drugs Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Zydus Cadila Antimycobacterial Drugs Product Portfolio

6.11.5 Zydus Cadila Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Antimycobacterial Drugs Industry Chain Analysis

7.2 Antimycobacterial Drugs Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Antimycobacterial Drugs Production Mode & Process Analysis

7.4 Antimycobacterial Drugs Sales and Marketing

7.4.1 Antimycobacterial Drugs Sales Channels

7.4.2 Antimycobacterial Drugs Distributors

7.5 Antimycobacterial Drugs Customer Analysis

8 Antimycobacterial Drugs Market Dynamics

8.1 Antimycobacterial Drugs Industry Trends

8.2 Antimycobacterial Drugs Market Drivers

8.3 Antimycobacterial Drugs Market Challenges

8.4 Antimycobacterial Drugs Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Macleods Pharmaceuticals

Systopic Laboratories

Zydus Cadila

List of Tables

Table 1. Global Antimycobacterial Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Antimycobacterial Drugs Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Antimycobacterial Drugs Market Competitive Situation by Manufacturers in 2024

Table 4. Global Antimycobacterial Drugs Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Antimycobacterial Drugs Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Antimycobacterial Drugs Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Antimycobacterial Drugs Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Antimycobacterial Drugs Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Antimycobacterial Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Antimycobacterial Drugs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Antimycobacterial Drugs, Product Type & Application

Table 12. Global Key Manufacturers of Antimycobacterial Drugs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Antimycobacterial Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antimycobacterial Drugs as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Antimycobacterial Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Antimycobacterial Drugs Sales by Region (2020-2025) & (K Units)

Table 18. Global Antimycobacterial Drugs Sales Market Share by Region (2020-2025)

Table 19. Global Antimycobacterial Drugs Sales by Region (2026-2031) & (K Units)

Table 20. Global Antimycobacterial Drugs Sales Market Share by Region (2026-2031)

Table 21. Global Antimycobacterial Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Antimycobacterial Drugs Revenue Market Share by Region (2020-2025)

Table 23. Global Antimycobacterial Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Antimycobacterial Drugs Revenue Market Share by Region (2026-2031)

Table 25. North America Antimycobacterial Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Antimycobacterial Drugs Sales by Country (2020-2025) & (K Units)

Table 27. North America Antimycobacterial Drugs Sales by Country (2026-2031) & (K Units)

Table 28. North America Antimycobacterial Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Antimycobacterial Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Antimycobacterial Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Antimycobacterial Drugs Sales by Country (2020-2025) & (K Units)

Table 32. Europe Antimycobacterial Drugs Sales by Country (2026-2031) & (K Units)

Table 33. Europe Antimycobacterial Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Antimycobacterial Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Antimycobacterial Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Antimycobacterial Drugs Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Antimycobacterial Drugs Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Antimycobacterial Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Antimycobacterial Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Antimycobacterial Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Antimycobacterial Drugs Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Antimycobacterial Drugs Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Antimycobacterial Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Antimycobacterial Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Antimycobacterial Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Antimycobacterial Drugs Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Antimycobacterial Drugs Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Antimycobacterial Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Antimycobacterial Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Antimycobacterial Drugs Sales (K Units) by Type (2020-2025)

Table 51. Global Antimycobacterial Drugs Sales (K Units) by Type (2026-2031)

Table 52. Global Antimycobacterial Drugs Sales Market Share by Type (2020-2025)

Table 53. Global Antimycobacterial Drugs Sales Market Share by Type (2026-2031)

Table 54. Global Antimycobacterial Drugs Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Antimycobacterial Drugs Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Antimycobacterial Drugs Revenue Market Share by Type (2020-2025)

Table 57. Global Antimycobacterial Drugs Revenue Market Share by Type (2026-2031)

Table 58. Global Antimycobacterial Drugs Price (USD/Unit) by Type (2020-2025)

Table 59. Global Antimycobacterial Drugs Price (USD/Unit) by Type (2026-2031)

Table 60. Global Antimycobacterial Drugs Sales (K Units) by Application (2020-2025)

Table 61. Global Antimycobacterial Drugs Sales (K Units) by Application (2026-2031)

Table 62. Global Antimycobacterial Drugs Sales Market Share by Application (2020-2025)

Table 63. Global Antimycobacterial Drugs Sales Market Share by Application (2026-2031)

Table 64. Global Antimycobacterial Drugs Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Antimycobacterial Drugs Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Antimycobacterial Drugs Revenue Market Share by Application (2020-2025)

Table 67. Global Antimycobacterial Drugs Revenue Market Share by Application (2026-2031)

Table 68. Global Antimycobacterial Drugs Price (USD/Unit) by Application (2020-2025)

Table 69. Global Antimycobacterial Drugs Price (USD/Unit) by Application (2026-2031)

Table 70. Pfizer Company Information

Table 71. Pfizer Description and Business Overview

Table 72. Pfizer Antimycobacterial Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Pfizer Antimycobacterial Drugs Product

Table 74. Pfizer Recent Developments/Updates

Table 75. Novartis Company Information

Table 76. Novartis Description and Business Overview

Table 77. Novartis Antimycobacterial Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Novartis Antimycobacterial Drugs Product

Table 79. Novartis Recent Developments/Updates

Table 80. GlaxoSmithKline Company Information

Table 81. GlaxoSmithKline Description and Business Overview

Table 82. GlaxoSmithKline Antimycobacterial Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. GlaxoSmithKline Antimycobacterial Drugs Product

Table 84. GlaxoSmithKline Recent Developments/Updates

Table 85. Bayer Company Information

Table 86. Bayer Description and Business Overview

Table 87. Bayer Antimycobacterial Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Bayer Antimycobacterial Drugs Product

Table 89. Bayer Recent Developments/Updates

Table 90. AstraZeneca Company Information

Table 91. AstraZeneca Description and Business Overview

Table 92. AstraZeneca Antimycobacterial Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. AstraZeneca Antimycobacterial Drugs Product

Table 94. AstraZeneca Recent Developments/Updates

Table 95. Sanofi Company Information

Table 96. Sanofi Description and Business Overview

Table 97. Sanofi Antimycobacterial Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Sanofi Antimycobacterial Drugs Product

Table 99. Sanofi Recent Developments/Updates

Table 100. Merck Company Information

Table 101. Merck Description and Business Overview

Table 102. Merck Antimycobacterial Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Merck Antimycobacterial Drugs Product

Table 104. Merck Recent Developments/Updates

Table 105. Lupin Company Information

Table 106. Lupin Description and Business Overview

Table 107. Lupin Antimycobacterial Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Lupin Antimycobacterial Drugs Product

Table 109. Lupin Recent Developments/Updates

Table 110. Macleods Pharmaceuticals Company Information

Table 111. Macleods Pharmaceuticals Description and Business Overview

Table 112. Macleods Pharmaceuticals Antimycobacterial Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. Macleods Pharmaceuticals Antimycobacterial Drugs Product

Table 114. Macleods Pharmaceuticals Recent Developments/Updates

Table 115. Systopic Laboratories Company Information

Table 116. Systopic Laboratories Description and Business Overview

Table 117. Systopic Laboratories Antimycobacterial Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 118. Systopic Laboratories Antimycobacterial Drugs Product

Table 119. Systopic Laboratories Recent Developments/Updates

Table 120. Zydus Cadila Company Information

Table 121. Zydus Cadila Description and Business Overview

Table 122. Zydus Cadila Antimycobacterial Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 123. Zydus Cadila Antimycobacterial Drugs Product

Table 124. Zydus Cadila Recent Developments/Updates

Table 125. Key Raw Materials Lists

Table 126. Raw Materials Key Suppliers Lists

Table 127. Antimycobacterial Drugs Distributors List

Table 128. Antimycobacterial Drugs Customers List

Table 129. Antimycobacterial Drugs Market Trends

Table 130. Antimycobacterial Drugs Market Drivers

Table 131. Antimycobacterial Drugs Market Challenges

Table 132. Antimycobacterial Drugs Market Restraints

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

Table 136. Authors List of This Report

List of Figures

Figure 1. Product Picture of Antimycobacterial Drugs

Figure 2. Global Antimycobacterial Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Antimycobacterial Drugs Market Share by Type: 2024 & 2031

Figure 4. Drugs Used for Tuberculosis Product Picture

Figure 5. Drugs Used for Leprosy Product Picture

Figure 6. Drugs Used for Atypical Mycobacteria Product Picture

Figure 7. Global Antimycobacterial Drugs Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Antimycobacterial Drugs Market Share by Application: 2024 & 2031

Figure 9. Hospital Pharmacies

Figure 10. Retail Pharmacies

Figure 11. Online Pharmacies

Figure 12. Global Antimycobacterial Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Antimycobacterial Drugs Market Size (2020-2031) & (US$ Million)

Figure 14. Global Antimycobacterial Drugs Sales (2020-2031) & (K Units)

Figure 15. Global Antimycobacterial Drugs Average Price (USD/Unit) & (2020-2031)

Figure 16. Antimycobacterial Drugs Report Years Considered

Figure 17. Antimycobacterial Drugs Sales Share by Manufacturers in 2024

Figure 18. Global Antimycobacterial Drugs Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Antimycobacterial Drugs Players: Market Share by Revenue in Antimycobacterial Drugs in 2024

Figure 20. Antimycobacterial Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Antimycobacterial Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Antimycobacterial Drugs Sales Market Share by Country (2020-2031)

Figure 23. North America Antimycobacterial Drugs Revenue Market Share by Country (2020-2031)

Figure 24. U.S. Antimycobacterial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Antimycobacterial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Antimycobacterial Drugs Sales Market Share by Country (2020-2031)

Figure 27. Europe Antimycobacterial Drugs Revenue Market Share by Country (2020-2031)

Figure 28. Germany Antimycobacterial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Antimycobacterial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Antimycobacterial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Antimycobacterial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Antimycobacterial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Antimycobacterial Drugs Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Antimycobacterial Drugs Revenue Market Share by Region (2020-2031)

Figure 35. China Antimycobacterial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Antimycobacterial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Antimycobacterial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Antimycobacterial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Antimycobacterial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Taiwan Antimycobacterial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Indonesia Antimycobacterial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Thailand Antimycobacterial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Malaysia Antimycobacterial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Philippines Antimycobacterial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Latin America Antimycobacterial Drugs Sales Market Share by Country (2020-2031)

Figure 46. Latin America Antimycobacterial Drugs Revenue Market Share by Country (2020-2031)

Figure 47. Mexico Antimycobacterial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Brazil Antimycobacterial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Argentina Antimycobacterial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Middle East and Africa Antimycobacterial Drugs Sales Market Share by Country (2020-2031)

Figure 51. Middle East and Africa Antimycobacterial Drugs Revenue Market Share by Country (2020-2031)

Figure 52. Turkey Antimycobacterial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Saudi Arabia Antimycobacterial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. UAE Antimycobacterial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Global Sales Market Share of Antimycobacterial Drugs by Type (2020-2031)

Figure 56. Global Revenue Market Share of Antimycobacterial Drugs by Type (2020-2031)

Figure 57. Global Antimycobacterial Drugs Price (USD/Unit) by Type (2020-2031)

Figure 58. Global Sales Market Share of Antimycobacterial Drugs by Application (2020-2031)

Figure 59. Global Revenue Market Share of Antimycobacterial Drugs by Application (2020-2031)

Figure 60. Global Antimycobacterial Drugs Price (USD/Unit) by Application (2020-2031)

Figure 61. Antimycobacterial Drugs Value Chain

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Anti Tuberculosis Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Tuberculosis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Mycobacterium Tuberculosis Testing Market Research Report 2024

Tuberculosis Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Mycobacterium Tuberculosis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Mycobacterium Tuberculosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Nontuberculous Mycobacterium Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anti tuberculosis Therapeutics Market Insights Forecast to 2030

Global Mycobacterium Tuberculosis Detection Kits Market Research Report 2025

Mycobacterium Abscessus Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Aminoglycoside Drug Market Research Report 2025

Global Anti Rheumatic Drugs Market Research Report 2024

Rifampicin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Drug Resistant Tuberculosis Treatment Market Research Report 2025

Global Anti infectives Medicine Market Research Report 2025

Global Mycobacterium Infections Treatment Market Research Report 2024

Global Anti tuberculosis APIs Market Research Report 2025

Anti tuberculosis Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Mycobacterium Tuberculosis Antibodies Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions